Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0100191136
Wed, 08.05.2024
Relief Therapeutics Holding SA
Relief Therapeutics Announces New Executive Leadership Team strengthening capabilities to guide the Company through pipeline development initiatives
GENEVA (MAY 8, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for sel [ … ]
Tue, 30.04.2024
Relief Therapeutics Holding SA
Relief Therapeutics has published its Annual Report
GENEVA (APR. 30, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today published its Annual Report 2023 and provided a corporate update. [ … ]
Fri, 26.04.2024
Relief Therapeutics Holding SA
Relief Therapeutics Holding SA
/ Key word(s): AGMEGM
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
26.04.2024 / 17:30 CET/CEST
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting of Shareholders Shareholders approved all proposals by a large majority
GEN [ … ]
Wed, 27.03.2024
Relief Therapeutics Holding SA
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General MeetingRelief Therapeutics Calls Extraordinary General Meeting
Anticipated Board of Directors Overhaul
GENEVA (MAR. 27, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief Therapeutics, or the Company), a biopharmaceutical company committed to delivering innova [ … ]
Fri, 22.03.2024
Relief Therapeutics Holding SA
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE®
GENEVA (MAR. 22, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare [ … ]
Wed, 28.02.2024
Relief Therapeutics Holding SA
Relief Therapeutics Renews CHF 50 million Share Subscription Facility
3-year CHF 50 million capital commitment from GEM
Relief advances strategic transformation
GENEVA (FEB. 28, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment [ … ]